Abou Samra Waleed Ali, Awad Eman Azmy, El Kannishy Amr Hassan
Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Eye Contact Lens. 2018 Sep;44 Suppl 1:S87-S91. doi: 10.1097/ICL.0000000000000333.
To evaluate the visual and topographic outcomes of a two-stage approach treatment for selected cases of progressive keratoconus (KC); corneal collagen cross-linking (CXL) followed by phacoemulsification with toric intraocular lens (IOL) implantation.
The study included 9 eyes of 6 patients diagnosed with progressive KC, aged from 35 to 47 years (41.6±11.2 years). All studied eyes underwent a two-stage approach treatment: first corneal collagen CXL followed after at least 6 months by phacoemulsification with foldable toric IOL implantation in both eyes of three patients and only one eye of the other three patients. A complete ophthalmological examination was performed preoperatively and postoperatively. Topographical and visual outcomes were evaluated during 1-year follow-up period.
At baseline, seven eyes had mild and two eyes had moderate KC. Sphere ranged from -3.00 to -8.00 diopter (D) and cylinder from -3.50 to -5.50 D. All eyes could be corrected by glasses to 0.50 (log of minimal angle of resolution [logMAR]) or more. At 6 months after CXL, only Kmax decreased significantly from baseline, with no change in visual acuity or manifest refraction. After phacoemulsification with toric IOL implantation, sphere changed from -5.74±1.88 D preoperatively to 0.33±0.72 D 12 months postoperatively (P<0.001), and cylinder changed from -4.53±0.98 to -1.10±0.76 D (P<0.001). There was significant improvement in mean uncorrected distance visual acuity from logMAR 1.43±0.51 preoperatively to 0.30±0.09 postoperatively (P<0.001) and the mean corrected distance visual acuity (CDVA) from 0.34±0.12 preoperatively to 0.24±0.13 (P=0.03) 1 year after IOL implantation. All patients were satisfied with their visual improvement.
This two-stage approach in selected cases of progressive KC is a safe and effective procedure regarding keratometric stability, and visual and refractive results.
评估两阶段治疗方法对部分进展期圆锥角膜(KC)病例的视觉和地形图结果;即先进行角膜胶原交联(CXL),然后行白内障超声乳化联合植入散光人工晶状体(IOL)。
该研究纳入了6例诊断为进展期KC的患者的9只眼,年龄在35至47岁之间(41.6±11.2岁)。所有研究眼均接受两阶段治疗:首先进行角膜胶原CXL,至少6个月后,3例患者的双眼及另外3例患者的单眼行可折叠散光IOL植入的白内障超声乳化术。术前和术后均进行了全面的眼科检查。在1年的随访期内评估地形图和视觉结果。
基线时,7只眼为轻度KC,2只眼为中度KC。球镜度数范围为-3.00至-8.00屈光度(D),柱镜度数范围为-3.50至-5.50 D。所有眼睛均可通过眼镜矫正至0.50(最小分辨角对数[logMAR])或更高。CXL术后6个月时,仅最大角膜曲率(Kmax)较基线显著降低,视力和明显屈光不正无变化。白内障超声乳化联合植入散光IOL后,球镜度数从术前的-5.74±1.88 D变为术后12个月的0.33±0.72 D(P<0.001),柱镜度数从-4.53±0.98变为-1.10±0.76 D(P<0.001)。平均未矫正远视力从术前的logMAR 1.43±0.51显著提高至术后的0.30±0.09(P<0.001),平均矫正远视力(CDVA)从术前的0.34±0.12提高至IOL植入术后1年的0.24±0.13(P=0.03)。所有患者对视力改善均满意。
对于部分进展期KC病例,这种两阶段治疗方法在角膜曲率稳定性、视觉和屈光结果方面是一种安全有效的手术。